TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987
TCL Archive Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers May 29, 1981
TCL Archive Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities: February 7, 1997
TCL Archive Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL April 28, 1995
